m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR

14Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The pathologic significance of the circular RNA DDIT4 (circDDIT4), which is formed by backsplicing at the 30-untranslated region (UTR) with a 50 splice acceptor site in exon 2 of linear DDIT4 mRNA, has yet to be determined. Our study found that circDDIT4 is downregulated in prostate cancer and functions as a tumor suppressor during prostate cancer progression. By competitively binding to ELAV-like RNA binding protein 1 (ELAVL1/HuR) through its 30-UTR, circDDIT4 acts as a protein sponge to decrease the expression of prostate cancer- overexpressed anoctamin 7 (ANO7). This promotes prostate cancer cell apoptosis while inhibiting cell proliferation and metastasis. Furthermore, we discovered that N6-methyladenosine (m6A) modification facilitates the biogenesis of circDDIT4. The methyltransferase complex consisting of WTAP/METTL3/- METTL14 increases the level of circDDIT4, while the RNA demethylase FTO decreases it.

Cite

CITATION STYLE

APA

Kong, Z., Lu, Y., Yang, Y., Chang, K., Lin, Y., Huang, Y., … Li, Y. (2023). m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR. Molecular Cancer Research, 21(12), 1342–1355. https://doi.org/10.1158/1541-7786.MCR-22-0271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free